Skip to content

CardioGenics Holdings Inc.: 10-K filed 2012-01-30

What CardioGenics Holdings Inc. reported in its annual report filed 2012-01-30 (fiscal FY 2011): 29 published measures, 107 facts as tagged in accession 0001144204-12-004759.

This filing

Form
10-K (annual report)
Filed
2012-01-30
Fiscal period
fiscal FY 2011
Accession
0001144204-12-004759 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CardioGenics Holdings Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-10-312,854,287USD
At 2010-10-312,486,135USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-10-312,726,851USD
At 2010-10-312,198,176USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-10-31669,202USD
At 2010-10-311,844,752USD
At 2009-10-312,388,516USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2010-11-01 to 2011-10-31-3,874,376USD365
1997-11-20 to 2011-10-31-38,880,934USD5094
2009-11-01 to 2010-10-31-2,024,272USD365
2008-11-01 to 2009-10-31-28,715,913USD365
2007-11-01 to 2008-10-31-1,331,408USD366
2006-11-01 to 2007-10-31-303,477USD365
2005-11-01 to 2006-10-31-522,532USD365
2004-11-01 to 2005-10-31-682,408USD365
2003-11-01 to 2004-10-31-592,706USD366
2002-11-01 to 2003-10-31-228,993USD365
2001-11-01 to 2002-10-31-156,214USD365
2000-11-01 to 2001-10-31-114,761USD365
1999-11-01 to 2000-10-31-152,525USD366
1998-11-01 to 1999-10-31-100,141USD365
1997-11-20 to 1998-10-31-81,208USD346

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2010-11-01 to 2011-10-31-1,409,013USD365
1997-11-20 to 2011-10-31-6,266,295USD5094
2009-11-01 to 2010-10-31-2,162,664USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2010-11-01 to 2011-10-3115,242USD365
1997-11-20 to 2011-10-31219,666USD5094
2009-11-01 to 2010-10-3111,058USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2010-11-01 to 2011-10-318,876USD365
1997-11-20 to 2011-10-318,876USD5094

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2010-11-01 to 2011-10-31317,218USD365
1997-11-20 to 2011-10-317,350,689USD5094
2009-11-01 to 2010-10-311,583,828USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2010-11-01 to 2011-10-31-33,006USD365
1997-11-20 to 2011-10-31-338,351USD5094
2009-11-01 to 2010-10-31-48,149USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-10-3182,308USD
At 2010-10-3187,465USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
1997-11-20 to 2011-10-312,508,282USD5094

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2010-11-01 to 2011-10-31-3,788,883USD365
1997-11-20 to 2011-10-31-24,393,898USD5094
2009-11-01 to 2010-10-31-1,981,845USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-10-312,074,232USD
At 2010-10-312,227,967USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-10-31442,407USD
At 2010-10-31559,296USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-10-319,002USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2010-11-01 to 2011-10-313,797,759USD365
1997-11-20 to 2011-10-3124,402,774USD5094
2009-11-01 to 2010-10-311,981,845USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2010-11-01 to 2011-10-31613,504USD365
1997-11-20 to 2011-10-313,814,877USD5094
2009-11-01 to 2010-10-31605,658USD365

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-10-3141,774,001USD
At 2010-10-3137,441,728USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-10-31-166,756USD
At 2010-10-31-237,508USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-10-312,409,250USD
At 2010-10-311,905,954USD
At 2009-10-311,964,119USD
At 2008-10-31-2,069,978USD
At 2007-10-31-1,371,103USD
At 2006-10-31-922,318USD
At 2005-10-31-381,053USD
At 2004-10-31247,496USD
At 2003-10-31513,767USD
At 2002-10-31272,818USD
At 2001-10-3134,156USD
At 2000-10-31131,582USD
At 1999-10-31-23,135USD
At 1998-10-318,482USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2011-10-31130,732USD
At 2010-10-31170,703USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2010-11-01 to 2011-10-31-3,899,755USD365
1997-11-20 to 2011-10-31-39,198,533USD5094
2009-11-01 to 2010-10-31-2,038,497USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2010-11-01 to 2011-10-31-3,803,624USD365
2009-11-01 to 2010-10-31-1,941,965USD365
2008-11-01 to 2009-10-31-29,245,209USD365
2007-11-01 to 2008-10-31-908,642USD366
2006-11-01 to 2007-10-31-487,909USD365
2005-11-01 to 2006-10-31-548,220USD365
2004-11-01 to 2005-10-31-695,696USD365
2003-11-01 to 2004-10-31-598,842USD366
2002-11-01 to 2003-10-31-186,036USD365
2001-11-01 to 2002-10-31-167,720USD365
2000-11-01 to 2001-10-31-125,289USD365
1999-11-01 to 2000-10-31-151,604USD366
1998-11-01 to 1999-10-31-103,630USD365
1997-11-20 to 1998-10-31-83,304USD346

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2010-11-01 to 2011-10-311,349,300USD365
1997-11-20 to 2011-10-315,625,408USD5094
2009-11-01 to 2010-10-311,246,887USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2010-11-01 to 2011-10-3120,399USD365
1997-11-20 to 2011-10-31201,439USD5094
2009-11-01 to 2010-10-3120,932USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2010-11-01 to 2011-10-315,207USD365
1997-11-20 to 2011-10-3112,411USD5094
2009-11-01 to 2010-10-313,023USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2010-11-01 to 2011-10-31-110,872USD365
1997-11-20 to 2011-10-31-14,766,924USD5094
2009-11-01 to 2010-10-31-134,348USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2010-11-01 to 2011-10-31347,747USD365
1997-11-20 to 2011-10-315,624,169USD5094
2009-11-01 to 2010-10-311,707,575USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2010-11-01 to 2011-10-319,002USD365
1997-11-20 to 2011-10-319,002USD5094

Inspect the source

Entity
CardioGenics Holdings Inc. / CIK 0001089029
Captured
SEC response SHA-256
fc1d26b5dc66df3e12f4b0071eebc7f92b6a2feccc83acfb92e8a5959410b4c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001089029.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))